• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Quantum-Si Incorporated

    12/22/25 7:38:37 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials
    Get the next $QSI alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001557736
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Quantum-Si Inc
    SEC File Number
    001-39486
    Address of Issuer
    29 BUSINESS PARK DRIVE
    BRANFORD
    CONNECTICUT
    06405
    Phone
    (203) 458-7100
    Name of Person for Whose Account the Securities are To Be Sold
    Keyes Jeffry R.
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Class A Common Stock
    Morgan Stanley Smith Barney LLC
    1 New York Plaza
    38th Floor
    New York � NY � 10004
    862711008.0594508812/22/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Class A Common Stock03/15/2024Restricted Stock Unit VestingQuantum-Si IncorporatedCheckbox not checked862703/15/2024Equity compensation for services rendered

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Morgan Stanley Smith Barney LLC
    1 New York Plaza
    38th Floor
    New York � NY � 10004
    Class A Common Stock09/22/202538736515.87
    Morgan Stanley Smith Barney LLC
    1 New York Plaza
    38th Floor
    New York � NY � 10004
    Class A Common Stock09/23/202538736331.54

    144: Remarks and Signature

    Remarks
    Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale is mandated by the Issuers election to require the satisfaction of tax withholding obligations through a sell to cover transaction and does not represent a discretionary trade by the reporting person.
    Date of Notice
    12/22/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Christian LaPointe, Ph.D., Attorney-in-Fact

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $QSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QSI

    DatePrice TargetRatingAnalyst
    2/7/2025$3.75Buy
    Alliance Global Partners
    12/8/2023$3.00Buy
    H.C. Wainwright
    9/25/2023$3.50 → $2.00Buy → Hold
    Canaccord Genuity
    10/20/2021$13.00Buy
    Canaccord Genuity
    More analyst ratings

    $QSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements

    New library prep kit enables detection of proteins with as little as 1-2 ng of input Data analysis enhancements unlock new amino acid detection Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the launch of the Version 3 Library Preparation Kit and a new suite of data analysis tool enhancements. When combined with the Version 4 Sequencing Kit which was launched in September 2025, the Company expects users will see significant improvements analyzing scarce biologic samples, complex mixtures, and detecting low abundance biomarkers. The Version 3 Library

    12/22/25 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 39,920 restricted stock units ("RSUs") to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the "2023 Inducement Plan"). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4). The 2023 Inducement Plan is used exclusively for the grant of equity awards t

    12/15/25 6:00:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day

    Expect Proteus launch by end of 2026 Demonstration of the detection of all 20 amino acids by end of 2026 New controlled cleavage chemistry unlocks path to billions of sequencing reads Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the highlights of its Investor & Analyst Day that was hosted in New York City on November 19, 2025. Key Highlights: Proteus™ platform on track for end of 2026 launch Early Access Program expected to start in the summer of 2026 Expect Proteus to have coverage of 18 amino acids at launch and overall sequencing

    11/20/25 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Keyes Jeffry R. bought $43,465 worth of shares (50,000 units at $0.87), increasing direct ownership by 13% to 446,820 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    8/13/24 6:01:25 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    President & CEO Hawkins Jeffrey Alan bought $21,272 worth of shares (25,000 units at $0.85), increasing direct ownership by 3% to 1,003,757 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    8/13/24 6:01:28 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Director Kummeth Charles R. bought $148,459 worth of shares (170,000 units at $0.87), increasing direct ownership by 92% to 355,000 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    8/13/24 6:01:24 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Quantum-Si with a new price target

    Alliance Global Partners initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.75

    2/7/25 8:29:38 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright initiated coverage on Quantum-Si with a new price target

    H.C. Wainwright initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.00

    12/8/23 7:55:31 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quantum-Si from Buy to Hold and set a new price target of $2.00 from $3.50 previously

    9/25/23 9:04:14 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    SEC Filings

    View All

    SEC Form 144 filed by Quantum-Si Incorporated

    144 - Quantum-Si Inc (0001816431) (Subject)

    12/22/25 7:38:37 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form 144 filed by Quantum-Si Incorporated

    144 - Quantum-Si Inc (0001816431) (Subject)

    12/22/25 7:19:05 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Quantum-Si Inc (0001816431) (Filer)

    11/20/25 8:06:26 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Leadership Updates

    Live Leadership Updates

    View All

    $QSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $QSI
    Financials

    Live finance-specific insights

    View All

    Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Charles ("Chuck") Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth's tenure at Bio-Techne, he oversaw tremendous growth across all aspects of the business including annual revenue growth from $300M to over $1.1B, growth in the employee base from 800 to over 3,000, and the successful execution of 19 acquisitions, all while maintaining a 35% or better EBITDA level. Under Mr. Ku

    5/30/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321183506/en/Paula Dowdy (Photo: Business Wire) Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at EQT Life Sciences, one of Europe's leading investors targeting innovative

    3/21/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company's protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a rich history dating back to the 1950s, will distribute Quantum-Si's next-generation protein sequencer™ and associated consumables throughout Japan. "Working with Quantum-Si marks a pivotal moment for TOMY Digital Biology, aligning with our commitment to advancing life sciences. We're poised to empower Japanese researchers wit

    1/18/24 8:30:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chief Product Officer Vieceli John S. sold $27,979 worth of shares (21,927 units at $1.28), decreasing direct ownership by 3% to 800,973 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    12/22/25 8:11:48 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    GC & Corp. Secretary Lapointe Christian sold $15,249 worth of shares (11,951 units at $1.28), decreasing direct ownership by 1% to 948,855 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    12/22/25 8:01:22 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Keyes Jeffry R. sold $11,008 worth of shares (8,627 units at $1.28), decreasing direct ownership by 0.74% to 1,163,197 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    12/22/25 7:50:21 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Reports Third Quarter 2025 Financial Results

    Announces Successful Sequencing on Prototype Proteus Unit, Development Program Remains On-Track Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the third quarter ended September 30, 2025. Press Release Highlights Reported revenue of $552,000 for the third quarter of 2025 Announced successful sequencing runs on a prototype Proteus system. The development program remains on track. Highlighted early success with instrument placement program, providing increased access to academic customers Highlighted recent launch and

    11/5/25 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the third quarter 2025 on Wednesday, November 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, ind

    10/13/25 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the second quarter 2025 on Tuesday, August 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, indivi

    7/14/25 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quantum-Si Incorporated

    SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

    9/17/24 4:24:56 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Quantum-Si Incorporated

    SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

    6/28/24 5:16:32 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Quantum-Si Incorporated

    SC 13G - Quantum-Si Inc (0001816431) (Subject)

    2/13/24 9:41:18 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials